Safety assessment of γ-cyclodextrin

Regulatory Toxicology and Pharmacology

Volumn 39, Issue SUPPL., 2004, Pages 3-13

  Munro, I C ^a   Newberne, P M ^b   Young, V R ^c   Bar A ^d  

^a CanTox Inc   (Canada)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d Bioresco AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; GAMMA CYCLODEXTRIN; PANCREAS ENZYME; RETINOL; VITAMIN; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DOG; EMBRYOTOXICITY; FEMALE; GASTROINTESTINAL TOXICITY; GENOTOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; REVIEW; RISK ASSESSMENT; SMALL INTESTINE; TERATOGENICITY; TOXICOLOGY; VITAMIN BLOOD LEVEL;

CANIS FAMILIARIS; ORYCTOLAGUS CUNICULUS;

EID: 3242693195     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yrtph.2004.05.008     Document Type: Article

References (64)

1. Abdullah M., French D., Robyt J.F. Multiple attack by α-amylases. Arch. Biochem. Biophys. 114:1966;595-598
2. Allegre M., Deratani A. Cyclodextrin uses: from concept to industrial reality. Agro Food Ind. Hi-Tech. 5(1):1994;9-17
3. Amann, M., Douglass, J., Doyle, E., Heimbach, J.T., 1998. Estimated intake of gamma-cyclodextrin in the US from food uses. Unpublished report of TAS-ENVIRON Inc., Arlington, VA
4. Bar R., Ulitzur S. Bacterial toxicity of cyclodextrins: luminuous Escherichia coli as a model. Appl. Microbiol. Biotechnol. 41:1994;574-577
5. Bárdos L., Gálné F.M., Szente L. Absorption of vitamin A from β-cyclodextrin inclusion complex. Allattenyé sztés Takarmányozás. 38:1989;263-268
6. Bellringer M.E., Smith T.G., Read R., Gopinath C., Olivier P. β-Cyclodextrin: 52-week toxicity studies in the rat and dog. Food Chem. Toxicol. 33:1995;367-376
7. Blijleven, W.G.H., 1991. Examination of γ-cyclodextrin for mutagenic activity in the Ames test. Report No. V91.027 of TNO-CIVO Institute, Zeist, The Netherlands
8. Connors K.A. Population characteristics of cyclodextrin complex stabilities in aqueous solution. J. Pharm. Sci. 84:1995;843-848
9. Coussement W., Van Cauteren H., Vandenberghe J., Vanparys P., Teuns G., Lampo A., Marsboom R. Toxicological profile of hydroxypropyl β-cyclodextrin (HP β-CD) in laboratory animals. Duchêne D. Minutes 5th International Symposium on Cyclodextrins. 1990;522-524 Editions de Santé Paris
10. 14C-γ-cyclodextrin in germfree and conventional rats. Regul. Toxicol. Pharmacol. 27(2):1998;150-158
11. De Vogel, N., van Delft, J.H.M., 1996. Chromosome aberration test with γ-cyclodextrin in cultured human lymphocytes. Report No V96.398 of TNO-CIVO Institutes, Zeist, The Netherlands
12. Ding D.S., Fu Y. Civet cat in China. Perfumer Flavorist. 11:1986;97-104
13. Donaubauer H.H., Fuchs H., Langer K.H., Bär A. Subchronic intravenous toxicity studies with γ-cyclodextrin in rats. Regul. Toxicol. Pharmacol. 27(2):1998;189-198
14. FAO 1998. Compendium of food additive specifications. FAO Food and Nutrition Paper 52 (Addendum 6): pp. 45-47
15. FDA Food and Drug Administration, 1990. 55 Fed. Reg. 10932, pp. 32-34, March 23, 1990
16. Fillastre J.P., Mignon F., Sraer J.D., Morel-Maroger L., Richet G. Insuffisance rénale aiguë reversible après traitement prolongé par le dextran. La Presse Méd. 75:1967;2535-2538
17. Frank D.W., Gray J.E., Weaver R.N. Cyclodextrin nephrosis in the rat. Am. J. Pathol. 83:1976;367-374
18. French D. The Schardinger dextrins. Adv. Carbohydr. Chem. 12:1957;189-260
19. Goel A., Nene S. A novel cyclomaltodextrin glucanotransferase from Bacillus firmus that degrades raw starch. Biotechnol. Lett. 17(4):1995;411-416
20. Hedges A.R., Shieh W.J., Sikorski C.T. Use of cyclodextrins for encapsulation in the use and treatment of food products. ACS Symp., Ser. 590:1995;60-71
21. Hiasa Y., Ohshima M., Kitahori Y., Yuasa T., Fujita T., Iwata C., Miyashiro A., Konishi N. Histochemical studies of β-cyclodextrin nephrosis in rats. J. Nara Med. Assoc. 32:1981;316-326
22. Immel, H.R., 1991. Examination of γ-cyclodextrin in the micronucleus test. Report No. V90.436 of TNO-CIVO Institutes, Zeist, The Netherlands
23. Irie T., Otagiri M., Sunada M., Uekama K., Ohtani Y., Yamada Y., Sugiyama Y. Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro. J. Pharm. Dyn. 5:1982;741-744
24. Jones B.J.M., Higgins B.E., Silk D.B.A. Glucose absorption from maltotriose and glucose oligomers in the human jejunum. Clin. Sci. 72:1987;409-414
25. Kief H., Engelbart K. Reabsorptive Vacuolisation der gewundenen Nierenhauptstücke (sog. osmotische Nephrose). Frankfurter Z. Path. 75:1966;53-65
26. Kondo H., Nakatani H., Hiromi K. In vitro action of human and porcine α-amylases on cyclo-maltooligosac- charides. Carbohydr. Res. 204:1990;207-213
27. Koutsou G.A., Storey D.M., Bär A. Gastrointestinal tolerance of γ-cyclodextrin in humans. Food Addit. Contam. 16(7):1999;313-317
28. Leroy-Lechat F., Wouessidjewe D., Andreux J.P., Puisieux F., Duchêne D. Evaluation of the cytotoxicity of cyclodextrins and hydroxypropylated derivatives. Int. J. Pharm. 101(1-2):1994;97-103
29. Lina, B.A.R., 1999. Chronic (1-year) toxicity study with γ-cyclodextrin in rats. Report No. V98.1008 of TNO Nutrition and Food Research Institute, Zeist, The Netherlands
30. Lina B.A.R., Bär A. Subchronic oral toxicity studies with γ-cyclodextrin in rats. Regul. Toxicol. Pharmacol. 27(2):1998;178-188
31. Linssen J.P.H., Voragen A.G.J., Hokse H. Cyclodextrinen en levensmiddelen. Voedingsmiddelentechnologie. 24(20):1991;23-27
32. Marshall J.J., Miwa I. Kinetic difference between hydrolyses of γ-cyclodextrin by human salivary and pancreatic α-amylases. Biochim. Biophys. Acta. 661:1981;142-147
33. Matsuda K., Mera Y., Segawa Y., Uchida I., Yokomine A., Takagi K. Acute toxicity study of γ-cyclodextrin (γ-CD) in mice and rats. Ogo Yakuri (Pharmacometrics). 26:1983;287-291
34. Matsuda K., Segawa Y., Yokomine A., Uchida I., Mera Y., Tokugawa H. Biodisposition of γ-cyclodextrin (γ-CD) in the rabbit and dog after intravenous administration. Oyo Yakuri (Pharmacometrics). 30:1985;889-896
35. Moss A.J., Levy A.S., Kim I., Park Y.K. Use of vitamin and mineral supplements in the United States: current users, types of products, and nutrients. vol. 174:1989;1-19 National Center for Health Statistics, Hyattsville, MD
36. Nagatomo S. Cyclodextrins-expanding the development of their functions and applications. Chem. Econ. Eng. Rev. 17:1985;28-34
37. Ohtani Y., Irie T., Uekama K., Fukunaga K., Pitha J. Differential effects of α-, β-, and γ-cyclodextrins on human erythrocytes. Eur. J. Biochem. 186:1989;17-22
38. Okada Y., Kubota Y., Koizumi K., Hizukuri S., Ohfuji T., Ogata K. Some properties and the inclusion behavior of branched cyclodextrins. Chem. Pharm. Bull. 36:1988;2176-2185
39. Prigge, H., Mayer-Ullmann, J.M., Naumann, K., Rössler, G., 1989. Nachweis von cis-8-cyclohexadecenon in einem Zibetkatzensekret. Unpublished report of Consortium für elektromische Industrie GmbH, München, Germany
40. Prinsen, M.K., 1990. Acute eye irritation/corrosion study with γ-cyclodextrin in albino rabbits. Report No. V90.405/200069 of TNO-CIVO Institutes, Zeist, The Netherlands
41. Prinsen, M.K., 1992. Sensitization study with γ-CD in guinea pigs (maximization test. Report No. V92.575/352063 of TNO-CIVO Institutes, Zeist, The Netherlands
42. Pszczola E. Production and potential food applications of cyclodextrins. Food Techn. 42:1988;96-100
43. Rajewski R.A., Traiger G., Bresnahan J., Jaberaboansari P., Stella V.J., Thompson D.O. Preliminary safety evaluation of parenterally administered sulfoalkyl ether β-cyclodextrin derivatives. J. Pharm. Sci. 84:1995;927-931
44. Rendleman J.A. Enhanced production of γ-cyclodextrin from corn syrup solids by means of cyclododecanone as selective complexant. Carbohydr. Res. 247:1993;223-237
45. Schmid G. Cyclodextrin glycosyltransferase production: yield enhancement by overexpression of cloned genes. Tibtech. 7:1989;244-248
46. Schmid G. Preparation and application of γ-cyclodextrin. Duchêne D. New Trends in Cyclodextrins and Derivatives. 1991;25-54 Editions de Santé Paris
47. Sicard P.J., Saniez M.-H. Biosynthesis of cycloglycosyltransferase and obtention of its enzymatic reaction products. Duchêne D. Cyclodextrins and their Industrial Uses. 1987;75-103 Editions de Santé Paris
48. Starnes R.L. Industrial potential of cyclodextrin glycosyl transferases. Cereal Food World. 35:1990;1094-1099
49. Subar A.F., Block G. Use of vitamin and mineral supplements: demographics and amounts of nutrients consumed. Am. J. Epidemiol. 132(6):1990;1091-1101
50. Szejtli J. Cyclodextrins in food, cosmetics and toiletries. Starch/Stärke. 34:1982;379-385
51. 3H-cholecalciferol by formation of its cyclodextrin complex. Pharmazie. 38:1983;100-101
52. Tamura H., Takada M., Shiomi K. The color stability and antioxidative activity of an anthocyanin and γ-cyclodextrin complex. Am. Chem. Soc. 1997;213. AGFD Abstr. No. 152
53. Thompson D.O. Cyclodextrins - enabling excipients: their present and future use in pharmaceuticals. Crit. Rev. Ther. Drug Carrier Syst. 14(1):1997;1-104
54. Thoss M., Schwabe L., Frömming K.H. Cyclodextrin- Einschlussverbindungen von Zitronen-, Orangen-, Hopfen- und Kamillenöl. Pharm. Ztg. Wiss. 6:1993;144-148
55. Til H.P., Bär A. Subchronic (13-week) oral toxicity study of γ-cyclodextrin in dogs. Regul. Toxicol. Pharmacol. 27(2):1998;159-165
56. Tonkova A. Bacterial cyclodextrin glucanotransferase. Enzyme Microb. Technol. 22:1998;678-686
57. Toyoda K., Shoda T., Uneyama C., Takada K., Takahashi M. Carcinogenicity study of β-cyclodextrin in F344 rats. Food Chem. Toxicol. 35:1997;331-336
58. Vaution Ch., Hutin M., Glomot F., Duchêne D. The use of cyclodextrins in various industries. Duchêne D. Cyclodextrins and their Industrials Uses. 1987;297-350 Editions de Santé Paris
59. Waalkens-Berendsen D.H., Smits-van Prooije A.E., Bär A. Embryotoxicity and teratogenicity study with γ-cyclodextrin in rabbits. Regul. Toxicol. Pharmacol. 27(2):1998;172-177
60. Waalkens-Berendsen D.H., Verhagen F.J.J., Bär A. Embryotoxicity and teratogenicity study with γ-cyclodextrin in rats. Regul. Toxicol. Pharmacol. 27(2):1998;166-171
61. WHO, 1987. Principles for the safety assessment of food additives and contaminants in food. Environmental Health Criteria 70 (at p. 82). World Health Organization, Geneva
62. WHO, 1999. Safety evaluation of certain food additives and contaminants. WHO Food Additives Series 42. World Health Organization, Geneva, pp. 183-202
63. WHO, 2000. Evaluation of certain food additives and contaminants. WHO Technical Report Series 896, p. 26-27, WHO, Geneva
64. Yoshida A., Arima H., Uekama K., Pitha J. Pharmaceutical evaluation of hydroxyalkyl ethers of β-cyclodextrins. Int. J. Pharm. 46:1988;217-222